coumarin has been researched along with isofraxidin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, H; Li, J; Li, X; Li, Z; Liu, Y; Yin, S; Zhang, L | 1 |
| Fakhri, S; Farzaei, MH; Kazemi-Afrakoti, S; Majnooni, MB; Mojarrab, M; Shokoohinia, Y | 1 |
1 review(s) available for coumarin and isofraxidin
| Article | Year |
|---|---|
Isofraxidin: Synthesis, Biosynthesis, Isolation, Pharmacokinetic and Pharmacological Properties.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Cardiotonic Agents; Coumarins; Eleutherococcus; Fraxinus; Humans; Matrix Metalloproteinases; Neuroprotective Agents; NF-kappa B; Solvents; Tumor Necrosis Factor-alpha | 2020 |
1 other study(ies) available for coumarin and isofraxidin
| Article | Year |
|---|---|
Isofraxidin, a coumarin component improves high-fat diet induced hepatic lipid homeostasis disorder and macrophage inflammation in mice.
Topics: Animals; Coumarins; Diet, High-Fat; Homeostasis; Humans; Interleukin-6; Liver; Macrophages; Male; Mice; NF-kappa B; Non-alcoholic Fatty Liver Disease; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2017 |